BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2525433)

  • 1. Cholinergic maturation and SCH 23390-induced catalepsy in the male rat pup.
    Fitzgerald LW; Hannigan JH
    Brain Res Dev Brain Res; 1989 May; 47(1):147-50. PubMed ID: 2525433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A; Kulkarni SK
    Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
    Meller E; Kuga S; Friedhoff AJ; Goldstein M
    Life Sci; 1985 May; 36(19):1857-64. PubMed ID: 3157851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
    Ogren SO; Fuxe K
    Neurosci Lett; 1988 Mar; 85(3):333-8. PubMed ID: 2966309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiological functions mediated by D1 dopamine receptors.
    Goldstein M; Kuga S; Shimizu Y; Meller E
    Adv Exp Med Biol; 1986; 204():189-95. PubMed ID: 2947428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.
    Levin ED
    Behav Neural Biol; 1988 Sep; 50(2):240-5. PubMed ID: 2906537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats.
    Rowlett JK; Pedigo NW; Bardo MT
    Pharmacol Biochem Behav; 1991 Dec; 40(4):829-34. PubMed ID: 1840081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W; Neuscheler P; Nagel J; Müller CE
    Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S; Cabib S
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
    Parashos SA; Marin C; Chase TN
    Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.
    Undie AS; Friedman E
    Psychopharmacology (Berl); 1988; 96(3):311-6. PubMed ID: 2906152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors.
    Ossowska K; Wardas J; Golembiowska K; Wolfarth S
    Brain Res; 1990 Jan; 506(2):311-5. PubMed ID: 2154287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinforced responding of the 11-day-old rat pup: synergistic interaction of D1 and D2 dopamine receptors.
    McDougall SA; Crawford CA; Nonneman AJ
    Pharmacol Biochem Behav; 1992 May; 42(1):163-8. PubMed ID: 1388275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.